Vasoconstrictors bind to their receptors on the cell surface to activate phospholipase C and Ca
2+ channels, resulting in the mobilization of Ca
2+ from intracellular are extracellular Ca
2+ pools and protein kinase C activation. Vasoconstrictors are also thought to activate a distinct cellular mechanism for downregulating 20kDa myosin light chain (MLC
20) phosphatase activity, which involves Rho p21 and protein kinase C, resulting in an increase in the Ca
2+ sensitivity of MLC
20 phosphorylation. Protein kinase C also appears to activate a MLC
20 phosphorylation-independent mechanism for contraction, contributing to the maintenance of agonist-induced contraction. On the other hand, vasorelaxants inhibit activation of phospholipase C and gating of Ca
2+ channels, or stimulate Ca
2+ extrusion across the plasma membrane, leading to a decrease in the [Ca
2+]i. Vasorelaxants also appear to stimulate MLC
20 phosphatase activity, resulting in a further reduction of contractile response. The modulatory mechanism for changing the Ca
2+ sensitivity, together with the major regulatory mechanism for cellular Ca
2+metabolism, plays an important role in regulating vascular smooth muscle tone.
View full abstract